Skip to main content

Centene Value Stock - Dividend - Research Selection

Centene

ISIN: US15135B1017 , WKN: 766458

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children\'s health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Centene Corp. stock outperforms competitors on strong trading day

2023-02-17
Shares of Centene Corp. inched 0.48% higher to $73.36 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...

Centene Corp. stock underperforms Thursday when compared to competitors

2023-02-16
Shares of Centene Corp. shed 0.12% to $73.01 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...

Amazon and Other Quality Stocks Have Been Hit Hard. They Could Be Buys.

2023-02-16
Some quality stocks are on sale, a perfect opportunity for investors interested in names that might have a particularly bright future.

Centene Corp. stock falls Wednesday, underperforms market

2023-02-15
Shares of Centene Corp. slumped 0.38% to $73.10 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...

Centene Corp. stock rises Tuesday, outperforms market

2023-02-14
Shares of Centene Corp. inched 0.41% higher to $73.38 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...

Health Net Awards $1.5 Million Grant to Keck School of Medicine to Enable Street Medicine Teams to Better Serve Unsheltered Populations Across California

2023-02-14
Health Net announced today it awarded a $1.5 million grant to Keck School of Medicine of USC's Street Medicine program (USC Street Medicine) to enable street medicine workforces across the state to better serve people who are unsheltered. Distributed over a three-year period, the funds will establish two programs that prepare street medicine workforces to bring care directly to unsheltered populations in the places where they live – on sidewalks, in parks, under bridges, in vehicles or anywhere

Centene price target lowered to $97 from $101 at Cowen

2023-02-14
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Centene Corp. stock rises Monday, still underperforms market

2023-02-13
Shares of Centene Corp. inched 0.47% higher to $73.08 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...

Stocks `disconnected from reality`; Morgan Stanley screens those `unfairly punished`

2023-02-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Bearish Bets: 3 Downgraded Stocks You Should Consider Shorting This Week

2023-02-12
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Incyte Corp. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.